Posts by Jason Lutjen
Issue Brief: Medications for Opioid and Alcohol Use Disorders: Research Insights for Criminal Justice Professionals
Key Takeaways Medications for Substance Use Disorders Are Effective Treatments. Methadone, buprenorphine, and naltrexone are FDA-approved medications for the treatment of opioid use disorder (OUD). Naltrexone, acamprosate, and disulfiram are FDA-approved medications for the treatment of alcohol use disorder (AUD). These medications are effective in reducing substance use and improving recovery outcomes. Patient Choice Matters.…
Read MoreIssue Brief: Treating Opioid Use Disorder in Justice-Involved Populations
Download the Issue Brief (PDF) Opioid use disorder (OUD) is a medical condition that is treatable. Individuals involved in the criminal justice system should be screened for OUD. Anyone with moderate to severe OUD should have access to medication treatment for OUD in all criminal justice settings and upon release. OUD is a treatable illness,…
Read MoreLEAP Investigator Dr. Matthew Akiyama Receives Prestigious NIDA Avenir Award
JCOIN Speaker Series: Deflection – Leveraging Police and First Responders to Create New Pathways to Treatment and Recovery (8-26-21)
JCOIN Training and Engagement Center (JTEC) Launches
Advances in Programs for Formerly Incarcerated Individuals
Tuesday, August 24, 2021 (12:30 – 1:30 PM EDT) Hosted by Wilson Center for Science and Justice at Duke Law Event RSVP: https://bit.ly/Reentryprograms Event Description: Join the Wilson Center for Science and Justice for an expert panel discussion about frontline programs for individuals returning from incarceration and how they can support re-entry with healthcare and…
Read MoreResearch Updates from 2020 LEAP Investigators
JCOIN launches CONNECT website to cultivate collaboration and discovery between researchers and practitioners
LEAP Scholars & Investigators Program 2021-2022
The Justice Community Opioid Innovation Network (JCOIN) brings together a national network of investigators collaborating with justice and behavioral health partners to study and disseminate evidence-informed approaches to ensure quality care is provided to individuals with opioid use disorder (OUD) in justice settings. The LEAP program is a 1-2 year education and mentorship program that…
Read MoreJCOIN Speaker Series: Reentry Research – Mitigating the Risk during Reentry for People with Substance Use Disorders (6-24-2021)
The risk of overdose death significantly increases during the first two weeks during entry into the community. In this webinar, presenters will discuss the latest research, science, and innovation around mitigating risk during reentry for people with opioid use disorders. Topics covered will include medications for opioid use disorder (MOUD), behavioral interventions, and establishing linkages…
Read More